AOP Orphan Pharmaceuticals AG ("AOP Orphan") and Lantibio, Inc. ("Lantibio") today announced positive final results from their placebo controlled, double-blinded Phase II clinical study of Moli1901, an experimental compound to treat cystic fibrosis ("CF"). Moli1901 is being developed by AOP Orphan ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The dyslexic brain may have a general problem forming perceptual categories, including the templates for printed letters and speech sounds, say USC neuroscientists. This is reflected in a reduced ability to filter out visual "noise" that can obscure a pattern, the researchers suggest. [click link fo...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Abbott announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA® (adalimumab) as a treatment for moderate-to-severe ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Harvard Medical School researchers have discovered one way that a hardy disease-causing bacteria could be surviving in the lungs of chronically infected cystic fibrosis (CF) patients."This work is important because pathogenic bacteria such as Pseudomonas aeruginosa (PA) use protein secretion systems...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Pediatric researchers at Yale School of Medicine have identified a gene on human chromosome 6 called DCDC2, which is linked to dyslexia, a reading disability affecting millions of children and adults. The researchers also found that a genetic alteration in DCDC2 leads to a disruption in the formatio...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The Washington Post on Wednesday examined how Bill Gates "could fundamentally alter the methodology of philanthropy" when he ends his duties at Microsoft to devote more time to the [click link for full article]
read more »
Source:http://www.medicalnewstoday.com DiscussBury
A team led by Johns Hopkins Children's Center scientists has identified and successfully tamed an overactive protein that plays a key role in cystic fibrosis (CF), a genetic disorder that interferes with the body's ability to transport chloride in and out of cells. [click link for full article]
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The Crohn's & Colitis Foundation of America (CCFA) and ConvaTec, a world-leading manufacturer of ostomy and wound care products, announced today the five regional recipients for the 2006 Great Comebacks® Program. Now in its 22nd year, the annual Great Comebacks® Program recognizes the inspirational ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
New data from a post hoc analysis of the PRECiSE clinical trial program demonstrated that the anti-TNF CIMZIATM (certolizumab pegol) maintained response and remission in patients with moderate to severe Crohn's disease, regardless of whether or not they had been previously treated with infliximab. [...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.